Search research articles
Contact Us
Filters
Showing results (41-50 of 65) with videos related to
Page
of 7
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
December 12, 2018
Systemic treatments for thymoma and thymic carcinoma: A systematic review
Thierry Berghmans, Valérie Durieux, Stéphane Holbrechts, et al.
BMC Cancer
|
September 22, 2023
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
Christelle Bouchart, Julie Navez, Ivan Borbath, et al.
Clinical Case Reports
|
October 31, 2014
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
Arianna Deidda, Claudia Pisanu, Donatella Garau, et al.
Radiation Research
|
January 13, 2011
Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition
Kenneth J Niermann, Luigi Moretti, Nicholas J Giacalone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 13, 2009
Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation
Christopher D Willey, Dakai Xiao, Tianxiang Tu, et al.
Radiation Research
|
June 14, 2011
A novel bioluminescence orthotopic mouse model for advanced lung cancer
Bo Li, Artour Torossian, Wenyan Li, et al.
Cancers
|
December 11, 2022
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
Martin Manderlier, Julie Navez, Matthieu Hein, et al.
Bulletin Du Cancer
|
July 21, 2009
A practice survey of the evolution of rectal cancer management: a Belgian Federal College of radiotherapy study
Nicolas Magné, Jean-François Daisne, Luigi Moretti, et al.
The Oncologist
|
November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
Luigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer
Robert Mutter, Bo Lu, David P Carbone, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 65) with videos related to
Sort By:
Page
of 7
Lung Cancer (Amsterdam, Netherlands)
|
December 12, 2018
Systemic treatments for thymoma and thymic carcinoma: A systematic review
Thierry Berghmans, Valérie Durieux, Stéphane Holbrechts, et al.
BMC Cancer
|
September 22, 2023
Preoperative treatment with mFOLFIRINOX or Gemcitabine/Nab-paclitaxel +/- isotoxic high-dose stereotactic body Radiation Therapy (iHD-SBRT) for borderline resectable pancreatic adenocarcinoma (the STEREOPAC trial): study protocol for a randomised comparative multicenter phase II trial
Christelle Bouchart, Julie Navez, Ivan Borbath, et al.
Clinical Case Reports
|
October 31, 2014
Squamous-cell carcinoma of the tongue following therapy of rheumatoid arthritis with abatacept
Arianna Deidda, Claudia Pisanu, Donatella Garau, et al.
Radiation Research
|
January 13, 2011
Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition
Kenneth J Niermann, Luigi Moretti, Nicholas J Giacalone, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 13, 2009
Enzastaurin (LY317615), a protein kinase C beta selective inhibitor, enhances antiangiogenic effect of radiation
Christopher D Willey, Dakai Xiao, Tianxiang Tu, et al.
Radiation Research
|
June 14, 2011
A novel bioluminescence orthotopic mouse model for advanced lung cancer
Bo Li, Artour Torossian, Wenyan Li, et al.
Cancers
|
December 11, 2022
Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
Martin Manderlier, Julie Navez, Matthieu Hein, et al.
Bulletin Du Cancer
|
July 21, 2009
A practice survey of the evolution of rectal cancer management: a Belgian Federal College of radiotherapy study
Nicolas Magné, Jean-François Daisne, Luigi Moretti, et al.
The Oncologist
|
November 10, 2009
Prognostic factors for resected non-small cell lung cancer with pN2 status: implications for use of postoperative radiotherapy
Luigi Moretti, David S Yu, Heidi Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 12, 2009
A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer
Robert Mutter, Bo Lu, David P Carbone, et al.
Page
of 7